Select Medical (NYSE:SEM) Downgraded to “Hold” Rating by Benchmark

Select Medical (NYSE:SEM) was downgraded by equities research analysts at Benchmark from a “buy” rating to a “hold” rating in a note issued to investors on Monday,Briefing.com Automated Import reports.

A number of other equities analysts have also recently weighed in on the company. Royal Bank of Canada boosted their price target on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Bank of America initiated coverage on Select Medical in a report on Tuesday, August 20th. They set a “buy” rating and a $42.00 target price for the company. Finally, StockNews.com lowered Select Medical from a “buy” rating to a “hold” rating in a research report on Thursday. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $40.75.

Select Medical Price Performance

Shares of SEM opened at $39.67 on Monday. The company has a market capitalization of $5.14 billion, a price-to-earnings ratio of 18.54, a price-to-earnings-growth ratio of 1.78 and a beta of 1.42. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The firm has a 50-day simple moving average of $35.19 and a 200-day simple moving average of $35.03. Select Medical has a fifty-two week low of $22.26 and a fifty-two week high of $40.98.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business’s revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.46 earnings per share. On average, equities research analysts anticipate that Select Medical will post 2.16 earnings per share for the current year.

Institutional Investors Weigh In On Select Medical

Several hedge funds and other institutional investors have recently bought and sold shares of SEM. Point72 Asset Management L.P. increased its position in shares of Select Medical by 144.2% in the third quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after acquiring an additional 1,216,263 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Select Medical by 5.3% during the 1st quarter. Vanguard Group Inc. now owns 12,997,891 shares of the health services provider’s stock valued at $391,886,000 after acquiring an additional 650,093 shares in the last quarter. Millennium Management LLC raised its holdings in shares of Select Medical by 183.9% during the second quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock worth $23,824,000 after acquiring an additional 440,140 shares in the last quarter. Hood River Capital Management LLC acquired a new stake in Select Medical during the second quarter valued at $14,819,000. Finally, Ceredex Value Advisors LLC purchased a new position in Select Medical in the second quarter valued at about $11,456,000. 89.48% of the stock is currently owned by institutional investors.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.